Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track will explore the latest discoveries in cancer biology, focusing on the molecular mechanisms underlying tumor development and progression. Researchers are invited to present their findings on genetic, epigenetic, and environmental factors influencing cancer pathogenesis.
This session will highlight novel therapeutic strategies and interventions in oncology, including targeted therapies and immunotherapy. Participants will discuss the efficacy and safety of emerging treatment modalities in various cancer types.
This track will delve into the role of precision medicine in tailoring cancer treatment to individual patient profiles. Presentations will focus on the integration of genomic data and biomarkers in clinical decision-making.
This session aims to discuss the translation of laboratory research into clinical applications in oncology. Researchers and clinicians will share insights on overcoming barriers to effective implementation of innovative therapies.
This track will emphasize the importance of patient-centered approaches in oncology care, including communication, shared decision-making, and psychosocial support. Presenters will explore strategies to enhance patient engagement and satisfaction.
This session will address the impact of health policy on cancer prevention, treatment, and survivorship. Experts will discuss current policies, challenges, and opportunities for improving access to quality oncology care.
This track will focus on the interactions between tumor cells and their microenvironment, including immune cells and stromal components. Presentations will highlight the implications of these interactions for cancer progression and therapy.
This session will cover the design and implementation of clinical trials in oncology, including innovative methodologies and statistical approaches. Researchers are encouraged to present their experiences and outcomes from recent trials.
This track will address the unique challenges faced in pediatric oncology, including diagnosis, treatment, and long-term survivorship. Experts will share advancements in research and clinical practices tailored to children with cancer.
This session will explore the epidemiological aspects of cancer, including risk factors, prevention strategies, and public health initiatives. Researchers will discuss the implications of their findings for cancer control and prevention efforts.
This track will highlight the role of emerging technologies, such as artificial intelligence and big data analytics, in advancing cancer research. Presenters will discuss how these innovations can enhance diagnostics, treatment planning, and patient outcomes.